tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Strategic Growth Potential and Robust R&D Drive Buy Rating for CSPC Pharmaceutical Group
RatingsStrategic Growth Potential and Robust R&D Drive Buy Rating for CSPC Pharmaceutical Group
5d ago
CSPC Pharmaceutical Group Reports 2024 Earnings Decline
PremiumCompany Announcements
CSPC Pharmaceutical Group Reports 2024 Earnings Decline
9d ago
CSPC Pharmaceutical Group Declares Final Dividend for 2024
PremiumCompany Announcements
CSPC Pharmaceutical Group Declares Final Dividend for 2024
10d ago
CSPC Pharmaceutical Group Reports 2024 Financial Results Amid Industry Transformation
PremiumCompany Announcements
CSPC Pharmaceutical Group Reports 2024 Financial Results Amid Industry Transformation
10d ago
CHJTF Earnings this Week: How Will it Perform?
PremiumPre-Earnings
CHJTF Earnings this Week: How Will it Perform?
12d ago
CSPC Pharmaceutical’s SYS6040 Receives Clinical Trial Approval in China
PremiumCompany AnnouncementsCSPC Pharmaceutical’s SYS6040 Receives Clinical Trial Approval in China
17d ago
CSPC Innovation Reports Significant Financial Decline in 2024
Premium
Company Announcements
CSPC Innovation Reports Significant Financial Decline in 2024
17d ago
CSPC Pharmaceutical Group Schedules Board Meeting for Annual Results
Premium
Company Announcements
CSPC Pharmaceutical Group Schedules Board Meeting for Annual Results
20d ago
CSPC’s JSKN003 Receives Breakthrough Therapy Designation in China
PremiumCompany Announcements
CSPC’s JSKN003 Receives Breakthrough Therapy Designation in China
20d ago
CSPC Pharmaceutical Gains U.S. FDA Approval for Cancer Drug Trials
PremiumCompany Announcements
CSPC Pharmaceutical Gains U.S. FDA Approval for Cancer Drug Trials
25d ago
CSPC Pharmaceutical’s JMT108 Receives Clinical Trial Approval in China
PremiumCompany Announcements
CSPC Pharmaceutical’s JMT108 Receives Clinical Trial Approval in China
1M ago
CSPC Pharmaceutical’s Sirolimus Injection Gains Breakthrough Therapy Status in China
PremiumCompany Announcements
CSPC Pharmaceutical’s Sirolimus Injection Gains Breakthrough Therapy Status in China
1M ago
CSPC Pharmaceutical Group Issues Profit Warning Amid Revenue Decline
PremiumCompany AnnouncementsCSPC Pharmaceutical Group Issues Profit Warning Amid Revenue Decline
1M ago
CSPC Pharmaceutical Partners with Radiance Biopharma for Global Development of Cancer Drug
Premium
Company Announcements
CSPC Pharmaceutical Partners with Radiance Biopharma for Global Development of Cancer Drug
2M ago
CSPC Pharmaceutical Gains Approval for New Indication of Enyitan
Premium
Company Announcements
CSPC Pharmaceutical Gains Approval for New Indication of Enyitan
2M ago
CSPC Pharmaceutical’s SYH2059 Tablets Receives U.S. Clinical Trial Approval
PremiumCompany Announcements
CSPC Pharmaceutical’s SYH2059 Tablets Receives U.S. Clinical Trial Approval
2M ago
CSPC Secures Clinical Trial Approval for Herpes Zoster Vaccine
PremiumCompany Announcements
CSPC Secures Clinical Trial Approval for Herpes Zoster Vaccine
2M ago
CSPC Pharmaceutical Group Announces Change of Share Registrar
PremiumCompany Announcements
CSPC Pharmaceutical Group Announces Change of Share Registrar
2M ago
CSPC Pharmaceutical Gains Approval for Regorafenib Tablets, Boosting Oncology Portfolio
PremiumCompany Announcements
CSPC Pharmaceutical Gains Approval for Regorafenib Tablets, Boosting Oncology Portfolio
3M ago
CSPC Innovation Reports Significant Profit Decline in 2024
PremiumCompany AnnouncementsCSPC Innovation Reports Significant Profit Decline in 2024
3M ago
CSPC Pharma’s New Cancer Drug Approved for U.S. Trials
Premium
Company Announcements
CSPC Pharma’s New Cancer Drug Approved for U.S. Trials
3M ago
CSPC Pharmaceutical Gains Approval for New Diabetes Drug
Premium
Company Announcements
CSPC Pharmaceutical Gains Approval for New Diabetes Drug
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >